Podcast Episodes
Back to Search
Why Early Revenue is the Most Credible Proof in Medtech: Interview with restor3d CEO Kurt Jacobus
In this episode of Medsider Radio, we sat down with Kurt Jacobus, co-founder and CEO of restor3d.
restor3d provides patient-specific orthopedic implan…
5 hours ago
Finding the Clinical Need Hiding in Plain Sight: Interview with LightForce CEO Alfred Griffin
In this episode of Medsider Radio, we sat down with Alfred Griffin, co-founder and CEO of LightForce.
LightForce is the developer of the world's first…
1 week ago
Regulatory Rigor as a Competitive Moat: Interview with Osteoboost CEO Laura Yecies
In this episode of Medsider Radio, we sat down with Laura Yecies, CEO of Osteoboost.
Osteoboost is the first FDA-cleared drug-free prescription treatm…
1 month ago
What It Takes to Win Physician Confidence: Interview with Secure Closure CEO Stephen Belcher
In this episode of Medsider Radio, we sat down with Stephen Belcher, co-founder and CEO of Secure Closure.
Secure Closure is developing Quattro-Close,…
1 month, 1 week ago
The Four-Risk Framework for Evaluating Medtech Opportunities: Interview with SonoVascular CEO Daniel Estay
In this episode of Medsider Radio, we sat down with Daniel Estay, founder and CEO of SonoVascular.
SonoVascular has developed a novel mechanical-pharm…
1 month, 2 weeks ago
Testing Demand Before Perfecting Technology: Interview with Eyebot CEO Matthias Hofmann
In this episode of Medsider Radio, we sat down with Matthias Hofmann, CEO of Eyebot.
Eyebot is commercializing retail kiosks that deliver quick, effic…
1 month, 3 weeks ago
How to Decide Where to Deploy Capital in Growth-Stage Medtech: Interview with CMR Surgical CEO Massimiliano (Max) Colella
In this episode of Medsider Radio, we sat down with Massimiliano (Max) Colella, CEO of CMR Surgical.
CMR Surgical is developing Versius, a surgical ro…
2 months ago
Designing Consumer-Facing Medical Technology: Interview with Indomo CEO Rick Bente
In this episode of Medsider Radio, we sat down with Rick Bente, co-founder and CEO of Indomo.
Indomo’s flagship device, ClearPen, is an investigationa…
2 months, 2 weeks ago
Why Commercial Discipline Starts Long Before Launch: Interview with RenovoRx CEO Shaun Bagai
In this episode of Medsider Radio, we sat down with Shaun Bagai, CEO of RenovoRx.
The company is developing targeted oncology therapies and is curren…
2 months, 3 weeks ago
Using Private Capital to Preserve Control: Interview with SynerFuse CEO Justin Zenanko
In this episode of Medsider Radio, we sat down with Justin Zenanko, co-founder & CEO of SynerFuse.
SynerFuse is developing the e-TLIF procedure, which…
3 months ago